Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - SEELOS THERAPEUTICS, INC. | v214147_ex31-2.htm |
| EX-23.1 - EX-23.1 - SEELOS THERAPEUTICS, INC. | v214147_ex23-1.htm |
| EX-32.2 - EX-32.2 - SEELOS THERAPEUTICS, INC. | v214147_ex32-2.htm |
| EX-32.1 - EX-32.1 - SEELOS THERAPEUTICS, INC. | v214147_ex32-1.htm |
| EX-31.1 - EX-31.1 - SEELOS THERAPEUTICS, INC. | v214147_ex31-1.htm |
| EX-10.12 - EX-10.12 - SEELOS THERAPEUTICS, INC. | v214147_ex10-12.htm |
| EX-10.10 - EX-10.10 - SEELOS THERAPEUTICS, INC. | v214147_ex10-10.htm |
| 10-K - 10-K - SEELOS THERAPEUTICS, INC. | v214147_10k.htm |
| EX-10.11 - EX-10.11 - SEELOS THERAPEUTICS, INC. | v214147_ex10-11.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-148060, 333-107137, 333-122114, 333-117717, 333-125565, 333-140110, 333-152591, 333-132611, 333-111894, 333-1055509, 333-96813, 333-46967, and 333-91957) and Form S-8 (Nos. 333-152284, 333-138598, and 333-93435) of our report dated March 31, 2010, relating to the 2009 and 2008 consolidated financial statements of Apricus Biosciences, Inc. (formerly known as NexMed, Inc.) and Subsidiaries, which appear in the Annual Report (Form 10-K) of Apricus Biosciences, Inc. and Subsidiaries for the year ended December 31, 2010. Such report includes an uncertainty paragraph with respect to the ability of Apricus Biosciences, Inc. and Subsidiaries to continue as a going concern. We were not engaged to
audit, review, or apply any procedures to the adjustments relating to the 15 to 1 reverse stock split described in Note 1 to the consolidated financial statements and, accordingly, we do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by EisnerAmper LLP.
/s/ Amper, Politziner & Mattia, LLP
March 10, 2011
Edison, New Jersey